SCHEMBL37888

SCHEMBL37888

CNS(=O)(=O)c1cc2c(=O)[nH]c(Cc3cccc(Cl)c3)nc2s1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.63
PDE9A O76083 1/20 0.48
PDE1A P54750 1/20 0.48
PDE1B Q01064 1/20 0.48
PDE1C Q14123 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.42
HTR1A P08908 2/20 0.41
HTR7 P34969 2/20 0.41
CCNE2 O96020 2/20 0.39
CCNE1 P24864 2/20 0.39
CDK2 P24941 2/20 0.39
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
CNR1 P21554 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38370 0.88 PDE5A (0.70) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL37554 0.87 PDE5A (0.66) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL3492301 0.78 PDE5A (1.00) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL38743 0.77 PDE5A (0.82) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL38463 0.77 PDE5A (0.69) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL16175587 0.76 PDE5A (0.74) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL4515609 0.76 PDE5A (0.76) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL941211 0.75 PDE5A (0.64) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL37669 0.74 PDE5A (0.59) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL38176 0.74 PDE5A (0.73) PDE5APDE9APDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012004900-A1 THIENOPYRIMIDINE COMPOUNDS ASKA PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 WO disclosed